![Matthew J. Carlyle](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew J. Carlyle
Directeur/Bestuurslid bij Bright Angel Therapeutics, Inc.
Profiel
Matthew J.
Carlyle is currently a Director at NEOMED-LABS, Inc., Bright Angel Therapeutics, Inc., and Neurasic Therapeutics, Inc. He is also a Partner at NDI Capital, Inc. since 2004.
In addition, he is a Member of CFA Institute and CFA Vancouver.
Previously, he worked as a Finance Director at Neuro Discovery, Inc. and as the Chief Financial Officer & Secretary at Allon Therapeutics, Inc. from 2001 to 2012.
Actieve functies van Matthew J. Carlyle
Bedrijven | Functie | Begin |
---|---|---|
CFA Institute
![]() CFA Institute Miscellaneous Commercial ServicesCommercial Services CFA Institute operates as non-profit organization, which engages in the provision of chartered financial analyst programs. It offers certificate in investment performance measurement program, investment foundations, and scholarship. The company was founded in 1965 and is headquartered in Charlottesville, VA. | Corporate Officer/Principal | - |
CFA Vancouver | Corporate Officer/Principal | - |
NDI Capital, Inc.
![]() NDI Capital, Inc. Investment ManagersFinance NDI Capital, Inc (NDI Capital) is a venture capital firm Founded in 2003 and headquartered in Vancouver, British Columbia. | Private Equity Investor | 01-09-2004 |
Bright Angel Therapeutics, Inc.
![]() Bright Angel Therapeutics, Inc. BiotechnologyHealth Technology Bright Angel Therapeutics, Inc. is a pre-clinical stage biotechnology company. It is focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is headquartered in Toronto, Canada. | Directeur/Bestuurslid | - |
Neurasic Therapeutics, Inc.
![]() Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurasic Therapeutics, Inc. develops opiate-sparing and pain-relieving drugs. The company was founded in June 2020 and is headquartered in Westmount, Canada. | Directeur/Bestuurslid | - |
NEOMED-LABS, Inc.
![]() NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology NEOMED-LABS, Inc. engages in operation of a contract research organization. It offers clinical immunology laboratory services. The company was founded by Max Fehlmann in March 4, 2015 and is headquartered in Montréal, Canada. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Matthew J. Carlyle
Bedrijven | Functie | Einde |
---|---|---|
Neuro Discovery, Inc. | Financieel Directeur/CFO | - |
ALLON THERAPEUTICS INC. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ALLON THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Neuro Discovery, Inc. | Commercial Services |
NDI Capital, Inc.
![]() NDI Capital, Inc. Investment ManagersFinance NDI Capital, Inc (NDI Capital) is a venture capital firm Founded in 2003 and headquartered in Vancouver, British Columbia. | Finance |
CFA Institute
![]() CFA Institute Miscellaneous Commercial ServicesCommercial Services CFA Institute operates as non-profit organization, which engages in the provision of chartered financial analyst programs. It offers certificate in investment performance measurement program, investment foundations, and scholarship. The company was founded in 1965 and is headquartered in Charlottesville, VA. | Commercial Services |
CFA Vancouver | |
NEOMED-LABS, Inc.
![]() NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology NEOMED-LABS, Inc. engages in operation of a contract research organization. It offers clinical immunology laboratory services. The company was founded by Max Fehlmann in March 4, 2015 and is headquartered in Montréal, Canada. | Health Technology |
Bright Angel Therapeutics, Inc.
![]() Bright Angel Therapeutics, Inc. BiotechnologyHealth Technology Bright Angel Therapeutics, Inc. is a pre-clinical stage biotechnology company. It is focused on the development of novel therapeutics for the treatment of drug-resistant and life-threatening fungal infections. The company is headquartered in Toronto, Canada. | Health Technology |
Neurasic Therapeutics, Inc.
![]() Neurasic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neurasic Therapeutics, Inc. develops opiate-sparing and pain-relieving drugs. The company was founded in June 2020 and is headquartered in Westmount, Canada. | Health Technology |